Substrate
science

Podcast Discusses Book on Silicon Valley and Research Integrity

A student author discusses a new book covering Silicon Valley practices and a past research integrity case. The interview appears in a recent podcast episode.

SC
1 source·May 28, 4:00 PM(1 day ago)·1m read
Podcast Discusses Book on Silicon Valley and Research Integritytheconversation.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

A podcast episode features an interview with a student author about a new book titled How to Rule the World. The book examines practices in Silicon Valley and returns to the author's prior work exposing a research integrity breach.

The discussion is conducted by a books and media editor.

The episode is presented as the latest installment in an ongoing podcast series. Listeners can access the episode through the platform where it was posted.

Key Facts

Book title
How to Rule the World
Interview subject
Student and author of the book
Topic coverage
Silicon Valley practices and research integrity case

Potential Impact

  1. 01

    Listeners may gain information about Silicon Valley practices described in the book.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count77 words
PublishedMay 28, 2026, 4:00 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Loaded 1Amplifying 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source